HOME >> MEDICINE >> NEWS
UK Teenage Cancer Trust demands government action to aid young cancer patients

agements."

It is common in the UK, and in many other countries, for childhood cancer treatment to be generic while that for adults is site specific. The two systems do not mesh well and those on the cusp suffer as a result a situation often exacerbated by lack of co-operation between adult and paediatric practitioners. "It's a glass wall that has to be smashed if our young people are to get the service they need and deserve," said Mrs Whiteson.

It is more urgent than ever to act, she said, because there are now more young people with cancer in the 15 to 24 age group than there are children with cancer. Some treated in childhood relapse in adolescence and many of the 60% of children cured need long-term follow up. It is likely that numbers in the 15 to 24 group will increase over the next decade due to growth in the teenage and young adult cohort compared to the expected increase in the child population.

Mrs Whiteson said that none of this seemed to have been sufficiently considered by the medical profession, hindering reorganisation of service delivery. Nor had the NHS made any infrastructure changes to care appropriately for young cancer patients.

"It is taking a charity Teenage Cancer Trust to show the way and inspire change. We have established eight specialist adolescent units in the UK and we have 12 more in the pipeline, each costing around 1 million. The UK, through TCT, is the only country in the world to have set up these units, although other countries where provision for young cancer patients is just as dire are now starting to follow suit."

The range of cancers affecting young people include childhood and adult cancers, and the biology of their tumours is often different. In a further pioneering move, TCT is to fund the world's first Chair in Adolescent Cancer, ploughing 250,000 annually over the next decade into research and treatment.

But, said Mrs Whiteson, government help was essential. TC
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-153-677-2181
Teenage Cancer Trust
1-Mar-2004


Page: 1 2 3 4

Related medicine news :

1. Teenage highs and lows
2. Teenage hormone therapy to reduce adult height of tall girls linked to reduced fertility
3. Teenage smoking still worryingly high: Girls twice as likely as boys to puff away
4. Teenagers with cancer are missing out on vital services
5. Teenage girls lacking in vitamin D
6. Teenage boys exposed to environmental pollutants
7. Teenagers, drinking and driving: a quick trip to the grave
8. Exercise Is The Best Means Of Weight Control In Teenagers
9. Higher Prices Wont Stop Teenage Smokers
10. Studies Find Public Policies For Children And Teenagers Not Very Effective
11. Combination Of Interventions Are Found To Be Most Effective In Improving Driving Behavior Among Teenagers

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: